SCHEMBL7294199

SCHEMBL7294199

NN=CN1CCC[C@@H](CNC(=O)C[C@H](NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)C(=O)N(CCC(=O)O)C2CC2)C1

nearest known ligand 0.44

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
F2 P00734 12/20 0.44
SCN9A Q15858 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.35
CXCR3 P49682 1/20 0.35
ALDH1A1 P00352 2/20 0.35
PKM P14618 1/20 0.35
DPP4 P27487 1/20 0.35
KCNH2 Q12809 1/20 0.35
DPP7 Q9UHL4 1/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7294190 0.89 F2 (0.55) F2
SCHEMBL7305122 0.87 F2 (0.59) F2
SCHEMBL7303162 0.87 F2 (0.44) F2
SCHEMBL7299083 0.84 F2 (0.44) F2ALDH1A1
SCHEMBL7297455 0.83 F2 (0.41) F2
SCHEMBL7294950 0.82 F2 (0.37) F2
Hydrochloric Acid SCHEMBL8947676 0.81 F2 (0.61) F2
Hydrochloric Acid SCHEMBL8947627 0.81 F2 (0.61) F2
Hydrochloric Acid SCHEMBL8947789 0.81 F2 (0.61) F2
Hydrochloric Acid SCHEMBL8716407 0.81 F2 (0.59) F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0559046-B1 N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors HOFFMANN LA ROCHE (CH) 2001-07-11 EP disclosed
US-5578594-A ANTICOAGULANTS HOFFMANN-LA ROCHE INC. (US) 1996-11-26 US disclosed
US-5405854-A Anticoagulants HOFFMANN-LA ROCHE INC. (US) 1995-04-11 US disclosed
EP-0559046-A1 N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1993-09-08 EP disclosed